RAVETA Trademark

Trademark Overview

On Friday, May 14, 2010, a trademark application was filed for RAVETA with the United States Patent and Trademark Office. The USPTO has given the RAVETA trademark a serial number of 85039197. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 21, 2019. This trademark is owned by Astellas Pharma Inc.. The RAVETA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of disorders of the nervous system, the cardiovascular system, the respiratory system, the digestive system, the reproductive system, the endocrine system, and the genitourinary system; pharmaceutical preparations for treatment of nephrological disorders, dermatological disorders, hematological disorders, immunological disorders and metabolic disorders; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of inflammation; antibiotics, antifungal preparations, anti-viral preparations; anticoagulants; antithrombotic agents; vaccines for the treatment of infectious diseases
raveta

General Information

Serial Number85039197
Word MarkRAVETA
Filing DateFriday, May 14, 2010
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 21, 2019
Registration Number4244208
Registration DateTuesday, November 20, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 3, 2012

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical preparations for the treatment of disorders of the nervous system, the cardiovascular system, the respiratory system, the digestive system, the reproductive system, the endocrine system, and the genitourinary system; pharmaceutical preparations for treatment of nephrological disorders, dermatological disorders, hematological disorders, immunological disorders and metabolic disorders; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of inflammation; antibiotics, antifungal preparations, anti-viral preparations; anticoagulants; antithrombotic agents; vaccines for the treatment of infectious diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 21, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstellas Pharma Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTokyo
JP
Party NameAstellas Pharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo
JP
Party NameAstellas Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo
JP

Trademark Events

Event DateEvent Description
Friday, June 21, 2019CANCELLED SEC. 8 (6-YR)
Monday, November 20, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, April 29, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 20, 2012REGISTERED-PRINCIPAL REGISTER
Wednesday, October 17, 20121(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, October 16, 2012NOTICE OF ALLOWANCE CANCELLED
Wednesday, October 17, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 16, 2012TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, May 29, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 3, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 3, 2012PUBLISHED FOR OPPOSITION
Wednesday, March 14, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 27, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, February 16, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 16, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 16, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 1, 2012TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, August 10, 2011NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, August 10, 2011INQUIRY TO SUSPENSION E-MAILED
Wednesday, August 10, 2011SUSPENSION INQUIRY WRITTEN
Wednesday, February 2, 2011NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, February 2, 2011LETTER OF SUSPENSION E-MAILED
Wednesday, February 2, 2011SUSPENSION LETTER WRITTEN
Monday, January 31, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 31, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 26, 2011TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, January 18, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 18, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 13, 2011ASSIGNED TO LIE
Friday, January 7, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 7, 2010NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Wednesday, July 7, 2010EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Wednesday, July 7, 2010EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Tuesday, June 29, 2010ASSIGNED TO EXAMINER
Thursday, May 20, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, May 18, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

raveta preparations system disorders treatment pharmaceutical antifungal anti inflammation viral antibiotics